International Cellular Medicine Society

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces

FDAADF

The FDA in the past year or so has issued draft guidances on regulation of stem cells that would, if finalized, make it crystal clear that what many American stem cell clinics are selling are unapproved drugs. That would be a good thing for patients who are often being put at risk by many of …

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces Read More »

Update on Cell Surgical Network IRB Status

Cell-Surgical-Network

The Cell Surgical Network is a for-profit network of clinics offering various stem cell-related interventions, which began with the California Stem Cell Treatment Center. I have interviewed Drs. Elliot Lander and Mark Berman of the Network in past (Part 1, Part 2) and I raised some concerns about the network in a follow up Part 3 post, …

Update on Cell Surgical Network IRB Status Read More »

ICMS posts 483 report of FDA audit: still awaiting news on Celltex

ICMS-IRB

The International Cellular Medicine Society (ICMS) is viewed somewhat skeptically by the stem cell community, but they are undeniably an important player in the stem cell world. A few weeks ago I interviewed ICMS President, Dr. Ricardo Rodriguez  (see interview here), and then I provided recommendations here to the ICMS to improve their organization including a less adversarial …

ICMS posts 483 report of FDA audit: still awaiting news on Celltex Read More »